Melanoma vaccine in phase 3: towards approval in 2025
Moderna and Merck's vaccine reduces melanoma death rate by 62%, moving closer to FDA approval in 2025
Moderna and Merck's vaccine reduces melanoma death rate by 62%, moving closer to FDA approval in 2025
The Netherlands converts COVID-19 disinfection points into free sunscreen dispensers to counter the increase in skin cancer cases.
A small, fast and highly accurate device detects melanoma with the same sensitivity as hospital diagnostics. It can be the turning point for routine visits.
The regenerative mechanism of the skin: a great mystery never fully understood. To date: A new study from the University of Manchester represents perhaps the definitive turning point.
An insight from a Mount Sinai team adds two ingredients to the melanoma vaccine that double its potency, and could prevent relapses.
Preventing melanoma is possible through the mapping of moles. Today NOTE mole tracker allows you to do it directly from home, with a dedicated device
Solar radiation is harmful to our body, you know. Yet you cannot shield everything with lead: a synthetic melanin can solve everything.
A joint study manages to isolate and identify DIRC3, a molecule that suppresses skin cancer. New hopes to stop melanoma.
The drug shows efficacy on mice in preventing the development of melanoma, related tumors and related metastases. The melanoma vaccine is reality.